(Q34639737)

3 August 2017

Torsades de pointes associated with fluoroquinolones (English)

1 reference

3 August 2017

1 reference

2

Paul G Ambrose

1 reference

3 August 2017

Robert C Owens

1

1 reference

PubMed ID

12013370

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

22

1 reference

3 August 2017

5

1 reference

3 August 2017

663-8; discussion 668-72

1 reference

The safety profile of the fluoroquinolones.

3 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Cisapride-induced torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Gatifloxacin-induced QTc prolongation and ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Moxifloxacin does increase the corrected QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

Reassuring safety profile of moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

The QT interval and torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.8.663.33201

10.1592/PHCO.22.8.663.33201

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12013370